Loading live market data…

4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

$11.7 USD

$0.4 (3.54%)

Volume
651.78K
Average Volume
872.77K
Market Capitalization
$611.63M
P/E Ratio
-4.40
Dividend Yield
0.00%
Price Target
$33.00
Year High
$14.00
Year Low
$4.11
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$9.34

FDMT Estimated and Actual Revenue by Quarter

FDMT Estimated and Actual EPS by Quarter

FDMT Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 3 -3.74M -3.74M -3.74M -3.74M -3.74M -3.74M
2026-09-30 4 -3.17M -3.17M -3.17M -3.17M -3.17M -3.17M
2026-06-30 4 -3.1M -3.1M -3.1M -3.1M -3.1M -3.1M
2026-03-31 4 -5.15M -20590 -2.59M -5.15M -20590 -2.59M
2025-12-31 5 -66.85M -70778 -27M -66.85M -70778 -27M
2025-09-30 3 -570.01K -5700 -287.86K -570.01K -5700 -287.86K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 3 -68.06M -68.06M -68.06M 951.58M 951.58M 951.58M
2026-09-30 4 -69M -68.33M -69M 807.27M 807.27M 807.27M
2026-06-30 4 -70.99M -67.01M -69M 790.29M 790.29M 790.29M
2026-03-31 4 -78.24M -58.68M -67.76M 5.24M 1.31B 658.93M
2025-12-31 5 -71.2M 27.12M -35.94M 18.02M 17.02B 6.88B
2025-09-30 3 -69.5M -64.26M -66.88M 1.45M 145.16M 73.31M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 3 3.74M 3.74M 3.74M 1 -1 -1 -1
2026-09-30 4 3.17M 3.17M 3.17M 5 -1.01375 -1.00391 -1.01375
2026-06-30 4 3.1M 3.1M 3.1M 5 -1.04299 -0.98451 -1.01375
2026-03-31 4 20590 5.15M 2.59M 6 -1.14951 -0.86213 -0.99556
2025-12-31 5 70778 66.85M 27M 7 -1.04604 0.39849 -0.528
2025-09-30 3 5700 570.01K 287.86K 7 -1.02113 -0.94407 -0.9826